HC Wainwright restated their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $18.00 price ...

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of $118.00.

BTCS Inc. (Nasdaq: BTCS) ("BTCS” or the "Company”), a leader in blockchain infrastructure and technology, is pleased to ...

HC Wainwright reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a $42.00 ...

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on Verona Pharma (VRNA) to $60 from $42 and keeps a Buy rating on the ...

If you want to stay updated on the latest options trades for SoundHound AI, Benzinga Pro gives you real-time options trades ...

Kapoor's target price reflects an upside potential for Summit of over 100%. Other Wall Street analysts are also bullish about ...

Cassava Sciences Inc (SAVA) stock saw a modest uptick, ending the day at $2.75 which represents a slight increase of $0.06 or 2.23% from the prior close of $2.69. The stock opened at $2.72 and touched ...

Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market ...

President Trump’s return the White House is expected to usher in a golden, if chaotic, age of crypto in the U.S., according ...

Vertex Pharmaceuticals Inc (VRTX) stock saw a modest uptick, ending the day at $422 which represents a slight increase of $5.04 or 1.21% from the prior close of $416.96. The stock opened at $422.73 ...